CN112336786A - Bezoar musk aphtha powder and preparation method thereof - Google Patents

Bezoar musk aphtha powder and preparation method thereof Download PDF

Info

Publication number
CN112336786A
CN112336786A CN201910731229.5A CN201910731229A CN112336786A CN 112336786 A CN112336786 A CN 112336786A CN 201910731229 A CN201910731229 A CN 201910731229A CN 112336786 A CN112336786 A CN 112336786A
Authority
CN
China
Prior art keywords
weight
parts
bezoar
musk
follows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910731229.5A
Other languages
Chinese (zh)
Inventor
杨宪青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yang Changlv
Original Assignee
Beijing Yangxianqing Traditional Chinese Medicine Culture Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Yangxianqing Traditional Chinese Medicine Culture Institute filed Critical Beijing Yangxianqing Traditional Chinese Medicine Culture Institute
Priority to CN201910731229.5A priority Critical patent/CN112336786A/en
Publication of CN112336786A publication Critical patent/CN112336786A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/28Mercury; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10Peat; Amber; Turf; Humus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/65Amphibians, e.g. toads, frogs, salamanders or newts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • A61K36/195Strobilanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315Isatis, e.g. Dyer's woad
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The application discloses bezoar and musk aphtha powder and a preparation method thereof, the bezoar and musk aphtha powder comprises the following raw materials: bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, natural indigo, Sichuan lotus, phellodendron bark and calamine. The bezoar musk aphtha powder of the application has better effect of treating the aphtha, less harm to the body and convenient taking through the synergistic effect of bezoar, musk, venenum bufonis, pearl, amber powder, black honeycomb, calcined peng sand, indigo naturalis, Sichuan lotus, golden cypress and calamine.

Description

Bezoar musk aphtha powder and preparation method thereof
Technical Field
The application relates to the technical field of traditional Chinese medicines, in particular to bezoar musk aphthous ulcer powder and a preparation method thereof.
Background
Aphtha of the mouth and tongue, swelling and aching of gum, throat inflammation and suppuration, hand-foot-and-mouth disease and otitis media suppuration become common diseases, and are treated by taking antibiotic medicines or infusion at present, so that the harm of antibiotics to the body is increased. Moreover, taking medicine and infusing are troublesome. Therefore, a traditional Chinese medicine with less harm to the body is needed.
Disclosure of Invention
It is an object of the present application to overcome the above problems or to at least partially solve or alleviate the above problems.
According to a first aspect of the application, the bezoar and musk aphthous ulcer powder comprises the following raw materials: bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, natural indigo, Sichuan lotus, phellodendron bark and calamine.
Optionally, the bezoar: 0.1-2 parts by weight of musk: 0.1-2 parts by weight of toad venom: 0.01-0.1 parts by weight of the pearl: 1-10 parts by weight of amber powder: 1-11 parts by weight of the black honeycomb: 1 to 9 parts by weight of the calcined foundry: 1-9 parts by weight of indigo naturalis: 1-10 parts by weight of Sichuan lotus: 1-10 parts by weight of phellodendron amurense: 1-10 parts by weight of calamine: 1 to 9 parts by weight.
Optionally, the bezoar: 0.3-1.8 parts by weight of musk: 0.3-1.7 parts by weight of toad venom: 0.02-0.09 parts by weight of the pearl: 2-9 parts by weight of amber powder: 1.5-10 parts by weight, the weight ratio of the black honeycomb: 2 to 8.5 parts by weight of the foundry: 1.5-8 parts by weight, indigo naturalis: 2-8 parts by weight of Sichuan lotus: 2-8.5 parts by weight of phellodendron amurense: 2-9 parts by weight of calamine: 1.5 to 8 parts by weight.
Optionally, the bezoar: 0.5-1.5 parts by weight of musk: 0.5-1.5 parts by weight of toad venom: 0.03-0.08 parts by weight of pearl: 2.5-8 parts by weight of amber powder: 2.4-8.5 parts by weight, the ratio of the black honeycomb: 2.6 to 7.5 parts by weight of the calcined sand: 2.4-7.5 parts by weight, indigo naturalis: 2.5-7 parts by weight of Sichuan lotus: 2.4-7.6 parts by weight, wherein the weight ratio of phellodendron amurense to phellodendron amurense is as follows: 3-8 parts by weight of calamine: 2.5 to 7 parts by weight.
Optionally, the bezoar: 0.8-1.2 parts by weight of musk: 0.8-1.2 parts by weight of toad venom: 0.04-0.07 parts by weight of pearl: 3.4-7 parts by weight of amber powder: 3.5-7 parts by weight, wherein the weight ratio of the black honeycomb: 3 to 7 parts by weight of the calcined foundry: 4-6.6 parts by weight of indigo naturalis: 3.5-6 parts by weight of Sichuan lotus: 3.5-6.5 parts by weight, wherein the weight ratio of phellodendron amurense to phellodendron amurense is as follows: 4-7 parts by weight of calamine: 3.5 to 6 parts by weight.
Optionally, the bezoar: 0.9-1.1 parts by weight of musk: 0.9-1.1 parts by weight of toad venom: 0.05-0.06 parts by weight of pearl: 4.5-6 parts by weight of amber powder: 4.5-6 parts by weight, the ratio of the black honeycomb: 4 to 6 parts by weight of the calcined foundry: 4.5-6 parts by weight, indigo naturalis: 4.2-5.6 parts by weight, wherein the weight ratio of the Sichuan lotus: 4.2-6 parts by weight of phellodendron amurense: 5-6 parts by weight of calamine: 4 to 5 parts by weight.
Optionally, the bezoar: 1 part by weight of musk: 1 part by weight of toad venom: 0.055 parts by weight, the pearl: 5 parts by weight of amber powder: 5.2 parts by weight of the black honeycomb: 5 parts by weight of the calcined foundry: 5.4 parts by weight of indigo naturalis: 5 parts by weight of Sichuan lotus: 5 parts by weight of phellodendron amurense: 5.5 parts by weight of calamine: 4.5 parts by weight.
Optionally, the feedstock further comprises the following components: making homo, Cinnabaris, Catechu and SANMEI tablet.
Optionally, the human whitening: 1-10 parts by weight of cinnabar: 1-10 parts by weight of catechu: 1-8 parts by weight of the three-plum slice: 1 to 9 parts by weight.
According to a second aspect of the application, a preparation method of bezoar and musk aphthous ulcer powder is provided, which comprises the following steps:
weighing: weighing the raw materials according to the formula of the first aspect;
a crushing step: crushing the pearls, the amber powder, the black honeycomb, the calcined sand, the indigo naturalis, the lotus, the golden cypress and the calamine in the raw materials to form crushed materials;
the synthesis steps are as follows: and putting the crushed materials into a container, uniformly stirring to form a mixture, putting the bezoar, the musk and the toad venom in the raw materials into the mixture, crushing, and sieving by using a sieve with more than 120 meshes to form the powder.
The bezoar musk aphtha powder of the application has better effect of treating the aphtha, less harm to the body and convenient taking through the synergistic effect of bezoar, musk, venenum bufonis, pearl, amber powder, black honeycomb, calcined peng sand, indigo naturalis, Sichuan lotus, golden cypress and calamine.
The above and other objects, advantages and features of the present application will become more apparent to those skilled in the art from the following detailed description of specific embodiments thereof, taken in conjunction with the accompanying drawings.
Drawings
Some specific embodiments of the present application will be described in detail hereinafter by way of illustration and not limitation with reference to the accompanying drawings. The same reference numbers in the drawings identify the same or similar elements or components. Those skilled in the art will appreciate that the drawings are not necessarily drawn to scale. In the drawings:
fig. 1 is a flowchart of a method for preparing bezoar musk ulcer powder according to an embodiment of the application.
Detailed Description
According to a first aspect of the application, the bezoar and musk aphthous ulcer powder comprises the following raw materials: bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, natural indigo, Sichuan lotus, phellodendron bark and calamine.
Wherein calculus bovis is administered orally for treating coma, mania, infantile convulsion, and convulsion; it is used externally to treat swelling and pain of throat, aphtha, carbuncle, swelling and uremia.
Moschus has heart tonifying, antibacterial, antiinflammatory, and immunity enhancing effects.
The Bufonis venenum has effects of removing toxic substance and relieving pain.
Pearl can be eaten for patients with fever, palpitation, insomnia, infantile convulsion, sore throat, ulcer, conjunctival congestion, and swelling and pain.
The black bee room is mainly used for treating pyocutaneous disease, pyogenic infection, rheumatalgia, toothache and the like, has the effects of dispelling wind and relieving spasm, detoxifying and treating sore, relieving pain and itching, and activating yang and removing arthralgia, and has the effects of inhibiting bacteria and resisting inflammation, promoting urination and reducing blood pressure and the like.
Indigo naturalis has effects of clearing heat and detoxicating, cooling blood, and arresting convulsion, and can be used for treating warm toxic macula, blood heat hematemesis, chest pain hemoptysis, aphtha, mumps, pharyngitis, and infantile convulsion.
The Szechuan lotus has the functions of clearing heat and reducing internal heat, eliminating dampness, purging pathogenic fire and removing toxicity, and is used for treating damp-heat fullness, vomiting and acid regurgitation, dysentery, jaundice, high fever and coma, hyperactivity of heart fire, vexation and insomnia, blood heat and hematemesis and epistaxis, conjunctival congestion, toothache, thirst, carbuncle swelling and furuncle, external treatment of eczema, ear purulence and aphtha.
Cortex Phellodendri has effects of clearing heat and detoxicating, purging pathogenic fire and eliminating dampness, and can be used for treating acute bacillary dysentery, acute enteritis, acute icteric hepatitis, urinary system infection, etc., and for treating fire scald, otitis media, acute conjunctivitis, etc. by external application.
The calamine has the effects of detoxifying, improving eyesight, removing nebula, astringing dampness, relieving itching and healing sore, and is used for treating conjunctival congestion, swelling and pain, conjunctival red rot, nebula membrane pterygium, unhealed ulcer, pus dribbling, eczema and skin pruritus.
The amber powder is mainly used for treating: palpitation and insomnia, infantile convulsion and epilepsy, stranguria with blood, hematuria, amenorrhea due to blood stagnation, postpartum abdominal pain due to blood stasis, abdominal mass, nebula, carbuncle, swelling and sore.
Used for external use, Zhongpeng Sand can clear heat and remove toxicity, relieve swelling and prevent corrosion, and is used in laryngology and ophthalmology to treat swollen sore throat and aphtha in the mouth and tongue, and it is often combined with Bing pian, Xuan Ming powder and Zhu Sha, etc. For eye diseases such as fire eye and pterygium, it can be ground into fine powder with Borneolum Syntheticum, Galamina, and Natrii sulfas for eye drop.
The bezoar musk aphtha powder of the application has better effect of treating the aphtha, less harm to the body and convenient taking through the synergistic effect of bezoar, musk, venenum bufonis, pearl, amber powder, black honeycomb, calcined peng sand, indigo naturalis, Sichuan lotus, golden cypress and calamine.
In the embodiment, the toad venom can be replaced by the laryngeal pill, the laryngeal pill contains the toad venom which is convenient to weigh, errors in the process of weighing the toad venom are avoided, and the toad venom is convenient to add.
In one embodiment, optionally, the bezoar: 0.1-2 parts by weight of musk: 0.1-2 parts by weight of toad venom: 0.01-0.1 parts by weight of the pearl: 1-10 parts by weight of amber powder: 1-11 parts by weight of the black honeycomb: 1 to 9 parts by weight of the calcined foundry: 1-9 parts by weight of indigo naturalis: 1-10 parts by weight of Sichuan lotus: 1-10 parts by weight of phellodendron amurense: 1-10 parts by weight of calamine: 1 to 9 parts by weight. By adding the proportions of the bezoar, the musk, the toad venom, the pearl, the amber powder, the black honeycomb, the calcined sand, the indigo naturalis, the Sichuan lotus, the golden cypress and the calamine, the effect of treating the ulcer is better, the harm to the body is less, and the administration is convenient.
In the above embodiment, optionally, the bezoar: 0.2-1.7 parts by weight of musk: 0.3-1.9 parts by weight of toad venom: 0.02 parts by weight of the pearl: 1.4-9.5 parts by weight of amber powder: 1.5-10.5 parts by weight, the ratio of the black honeycomb: 1.6 to 8.4 parts by weight of the calcined sand: 1.5-8.5 parts by weight, indigo naturalis: 1.6-9.4 parts by weight, wherein the weight ratio of the Sichuan lotus: 1.6-9.5 parts by weight, wherein the weight ratio of phellodendron amurense to phellodendron amurense is as follows: 1.6-9.4 parts by weight, preparing calamine: 1.5 to 8.4 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In one embodiment, optionally, the bezoar: 0.3-1.8 parts by weight of musk: 0.3-1.7 parts by weight of toad venom: 0.02-0.09 parts by weight of the pearl: 2-9 parts by weight of amber powder: 1.5-10 parts by weight, the weight ratio of the black honeycomb: 2 to 8.5 parts by weight of the foundry: 1.5-8 parts by weight, indigo naturalis: 2-8 parts by weight of Sichuan lotus: 2-8.5 parts by weight of phellodendron amurense: 2-9 parts by weight of calamine: 1.5 to 8 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In the above embodiment, optionally, the bezoar: 0.4-1.7 parts by weight of musk: 0.4-1.6 parts by weight of toad venom: 0.03 part by weight of the pearl: 2.4-8.6 parts by weight of amber powder: 2.2-9.4 parts by weight, wherein the weight ratio of the black honeycomb: 2.2 to 8 parts by weight of the foundry sand: 2.3-7.6 parts by weight, indigo naturalis: 2.3-7.6 parts by weight, wherein the weight ratio of the Sichuan lotus: 2.4-7.5 parts by weight, phellodendron bark: 2.3-8.3 parts by weight, preparing calamine: 1.8 to 7.6 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In one embodiment, optionally, the bezoar: 0.5-1.5 parts by weight of musk: 0.5-1.5 parts by weight of toad venom: 0.03-0.08 parts by weight of pearl: 2.5-8 parts by weight of amber powder: 2.4-8.5 parts by weight, the ratio of the black honeycomb: 2.6 to 7.5 parts by weight of the calcined sand: 2.4-7.5 parts by weight, indigo naturalis: 2.5-7 parts by weight of Sichuan lotus: 2.4-7.6 parts by weight, wherein the weight ratio of phellodendron amurense to phellodendron amurense is as follows: 3-8 parts by weight of calamine: 2.5 to 7 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In the above embodiment, optionally, the bezoar: 0.6-1.6 parts by weight of musk: 0.6-1.6 parts by weight of toad venom: 0.045 parts by weight, the pearl: 3.3-7.2 parts by weight of amber powder: 3.3-8.2 parts by weight, the ratio of the black honeycomb: 2.8 to 7.3 parts by weight of the calcined sand: 2.6-7.3 parts by weight, indigo naturalis: 2.8-6.6 parts by weight, wherein the weight ratio of the Sichuan lotus: 2.6-7 parts by weight of phellodendron amurense: 3.3-7.2 parts by weight, preparing calamine: 2.8 to 6.8 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In one embodiment, optionally, the bezoar: 0.8-1.2 parts by weight of musk: 0.8-1.2 parts by weight of toad venom: 0.04-0.07 parts by weight of pearl: 3.4-7 parts by weight of amber powder: 3.5-7 parts by weight, wherein the weight ratio of the black honeycomb: 3 to 7 parts by weight of the calcined foundry: 4-6.6 parts by weight of indigo naturalis: 3.5-6 parts by weight of Sichuan lotus: 3.5-6.5 parts by weight, wherein the weight ratio of phellodendron amurense to phellodendron amurense is as follows: 4-7 parts by weight of calamine: 3.5 to 6 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In one embodiment, optionally, the bezoar: 0.9-1.1 parts by weight of musk: 0.9-1.1 parts by weight of toad venom: 0.05-0.06 parts by weight of pearl: 4.5-6 parts by weight of amber powder: 4.5-6 parts by weight, the ratio of the black honeycomb: 4 to 6 parts by weight of the calcined foundry: 4.5-6 parts by weight, indigo naturalis: 4.2-5.6 parts by weight, wherein the weight ratio of the Sichuan lotus: 4.2-6 parts by weight of phellodendron amurense: 5-6 parts by weight of calamine: 4 to 5 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In one embodiment, optionally, the bezoar: 1 part by weight of musk: 1 part by weight of toad venom: 0.055 parts by weight, the pearl: 5 parts by weight of amber powder: 5.2 parts by weight of the black honeycomb: 5 parts by weight of the calcined foundry: 5.4 parts by weight of indigo naturalis: 5 parts by weight of Sichuan lotus: 5 parts by weight of phellodendron amurense: 5.5 parts by weight of calamine: 4.5 parts by weight. By improving the proportion of bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, indigo naturalis, Sichuan lotus, phellodendron and calamine, the prescription for treating the ulcer has better effect, less harm to the body and convenient taking.
In one embodiment, optionally, the feedstock further comprises the following components: making homo, Cinnabaris, Catechu and SANMEI tablet.
When used for treating leukorrhagia, it can clear heat, reduce pathogenic fire, remove blood stasis, treat internal heat, consumptive lung disease, epistaxis, hematemesis, pharyngitis, ulcerative gingivitis, aphtha and tongue ulcer.
Cinnabaris has effects of clearing heart fire, relieving convulsion, tranquilizing mind, improving eyesight, and removing toxic substance, and can be used for treating palpitation, insomnia, dreaminess, epilepsy, mania, infantile convulsion, blurred vision, aphtha, pharyngitis, pyocutaneous disease, and toxic swelling.
Sanmei tablet is used for treating pharyngitis, toothache, aphtha, carbuncle , conjunctival congestion, and nebula.
The infantile tea has the effects of astringing dampness, promoting granulation, healing sore and stopping bleeding, and is used for treating unhealed ulcer, eczema, aphtha, traumatic injury and bleeding due to trauma.
By adding middle-jiao white, cinnabar, catechu and sanmei tablets, the medicine can further lower fire, detoxify, relieve pain and stop bleeding.
In the above embodiment, optionally, the person-making chinese: 1-10 parts by weight of cinnabar: 1-10 parts by weight of catechu: 1-8 parts by weight of the three-plum slice: 1 to 9 parts by weight. By adding the proportion of white, cinnabar, catechu and sanmei tablets, the traditional Chinese medicine can further lower fire, detoxify, relieve pain and stop bleeding.
In the above embodiment, optionally, the person-making chinese: 2-8 parts by weight of cinnabar: 3-8 parts by weight of catechu: 2.5-7 parts by weight of the three-plum slice: 3 to 7.5 parts by weight. By changing the proportion of the white ginseng, the cinnabar, the catechu and the three-plum tablet, the traditional Chinese medicine can further lower fire, detoxify, relieve pain and stop bleeding.
In the above embodiment, optionally, the person-making chinese: 4-7 parts by weight of cinnabar: 4-7 parts by weight of catechu: 4-6 parts by weight of the three-plum slice: 4 to 7 parts by weight. By changing the proportion of the white ginseng, the cinnabar, the catechu and the three-plum tablet, the traditional Chinese medicine can further lower fire, detoxify, relieve pain and stop bleeding.
In the above embodiment, optionally, the person-making chinese: 5.4 parts by weight of cinnabar: 5.4 parts by weight of catechu: 5 parts by weight of the three-plum slice: 5.6 parts by weight. By changing the proportion of the white ginseng, the cinnabar, the catechu and the three-plum tablet, the traditional Chinese medicine can further lower fire, detoxify, relieve pain and stop bleeding.
Typical clinical experimental examples of bezoar belamcanda powder for treating oral ulcer:
case 1, male and 5 years old patients had excessive fat food, excessive pig bone soup and confectionary, red and swollen gums, inflammation and ulceration, two or thirty ulceration points with different sizes on the upper and lower sides of the throat and the tongue, running water, no diet, and crying and screaming for two nights, although the medicine taking is not good, the bezoar and the aphthous powder are used to blow the whole oral cavity once every two hours, and the ointment is pasted on Yongquan acupoints, so that the children stop crying and screaming for three to four times, the patients can drink water, can drink porridge soup, sleep for three days at night, and can be healed basically once to two days. The disease is observed to have no relapse for one year.
Case 2. female, 3 years old, infected, cold-fever, swollen sore throat, dozens of ulcers with different sizes in the oral cavity, numerous red eruptions and purulent vesicles in the hands, feet, buttocks, thighs to lower limbs, and diagnosed as hand-foot-and-mouth disease. By introduction, the bezoar belamcanda powder is blown to an affected part, ointment is pasted on a Yongquan point, the medicine is taken once in two hours, crying is basically stopped after two and three times, the medicine is taken continuously for two days and then is obviously improved, the medicine is blown once in three hours, no canker sore is seen after four days, the medicine can be eaten, the mouth ulcer is completely healed, and the disease does not relapse after observation for one year.
Case 3. patient 8 years old, because of in vivo accumulated heat, in addition to bathing in the ear water inflow, scratch the ear inflammation and purulence, pain all night, sleep uneasy, through introduction, after cleaning in the ear, blow this bezoar and penetrate the ulcer powder immediately and painlessly, blow once in three hours, after two days, no purulence, sleep also steady, after observation no recurrence for one year.
According to a second aspect of the application, a preparation method of bezoar and musk aphthous ulcer powder is provided, which comprises the following steps:
weighing: weighing the raw materials according to the formula of the first aspect;
a crushing step: crushing the pearls, the amber powder, the black honeycomb, the calcined sand, the indigo naturalis, the lotus, the golden cypress and the calamine in the raw materials to form crushed materials;
the synthesis steps are as follows: and putting the crushed materials into a container, uniformly stirring to form a mixture, putting the bezoar, the musk and the toad venom in the raw materials into the mixture, crushing, and sieving by using a sieve with more than 120 meshes to form the powder.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which this application belongs.
In the description of the present application, it is to be understood that the terms "central," "longitudinal," "lateral," "length," "width," "thickness," "upper," "lower," "front," "rear," "left," "right," "vertical," "horizontal," "top," "bottom," "inner," "outer," "clockwise," "counterclockwise," "axial," "radial," "circumferential," and the like are used in the orientations and positional relationships indicated in the drawings for convenience in describing the present application and to simplify the description, and are not intended to indicate or imply that the referenced devices or elements must have a particular orientation, be constructed and operated in a particular orientation, and are therefore not to be considered limiting of the present application.
Furthermore, the terms "first", "second", etc. are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. In the description of the present application, "a plurality" means two or more unless specifically defined otherwise.
In this application, unless expressly stated or limited otherwise, the terms "mounted," "connected," "secured," and the like are to be construed broadly and can include, for example, fixed connections, removable connections, or integral parts; can be mechanically or electrically connected; either directly or indirectly through intervening media, either internally or in any other relationship. The specific meaning of the above terms in the present application can be understood by those of ordinary skill in the art as appropriate.
In this application, unless expressly stated or limited otherwise, the first feature "on" or "under" the second feature may be directly contacting the first and second features or indirectly contacting the first and second features through intervening media. Also, a first feature "on," "over," and "above" a second feature may be directly or diagonally above the second feature, or may simply indicate that the first feature is at a higher level than the second feature. A first feature being "under," "below," and "beneath" a second feature may be directly under or obliquely under the first feature, or may simply mean that the first feature is at a lesser elevation than the second feature.
The above description is only for the preferred embodiment of the present application, but the scope of the present application is not limited thereto, and any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present application should be covered within the scope of the present application. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.

Claims (10)

1. The bezoar and musk aphtha powder comprises the following raw materials:
bezoar, musk, toad venom, pearl, amber powder, black honeycomb, calcined sand, natural indigo, Sichuan lotus, phellodendron bark and calamine.
2. The bezoar musk oroulcer powder according to claim 1, which is characterized in that:
the bezoar is as follows: 0.1 to 2 parts by weight;
the musk is as follows: 0.1 to 2 parts by weight;
the toad venom comprises the following components: 0.01 to 0.1 part by weight;
the pearl is as follows: 1-10 parts by weight;
the amber powder comprises the following components: 1 to 11 parts by weight;
the black honeycomb: 1-9 parts by weight;
the calcination sand: 1-9 parts by weight;
and (3) indigo naturalis: 1-10 parts by weight;
the lotus rhizome: 1-10 parts by weight;
the golden cypress: 1-10 parts by weight;
preparing calamine: 1 to 9 parts by weight.
3. The bezoar musk oroulcer powder according to claim 1, which is characterized in that:
the bezoar is as follows: 0.3 to 1.8 parts by weight;
the musk is as follows: 0.3 to 1.7 parts by weight;
the toad venom comprises the following components: 0.02-0.09 weight part;
the pearl is as follows: 2-9 parts by weight;
the amber powder comprises the following components: 1.5-10 parts by weight;
the black honeycomb: 2-8.5 parts by weight;
the calcination sand: 1.5-8 parts by weight;
and (3) indigo naturalis: 2-8 parts by weight;
the lotus rhizome: 2-8.5 parts by weight;
the golden cypress: 2-9 parts by weight;
preparing calamine: 1.5 to 8 parts by weight.
4. The bezoar musk oroulcer powder according to claim 1, which is characterized in that:
the bezoar is as follows: 0.5 to 1.5 parts by weight;
the musk is as follows: 0.5 to 1.5 parts by weight;
the toad venom comprises the following components: 0.03-0.08 weight part;
the pearl is as follows: 2.5-8 parts by weight;
the amber powder comprises the following components: 2.4-8.5 parts by weight;
the black honeycomb: 2.6 to 7.5 parts by weight;
the calcination sand: 2.4-7.5 parts by weight;
and (3) indigo naturalis: 2.5-7 parts by weight;
the lotus rhizome: 2.4-7.6 parts by weight;
the golden cypress: 3-8 parts by weight;
preparing calamine: 2.5 to 7 parts by weight.
5. The bezoar musk oroulcer powder according to claim 1, which is characterized in that:
the bezoar is as follows: 0.8 to 1.2 parts by weight;
the musk is as follows: 0.8 to 1.2 parts by weight;
the toad venom comprises the following components: 0.04 to 0.07 part by weight;
the pearl is as follows: 3.4-7 parts by weight;
the amber powder comprises the following components: 3.5-7 parts by weight;
the black honeycomb: 3-7 parts by weight;
the calcination sand: 4-6.6 parts by weight;
and (3) indigo naturalis: 3.5-6 parts by weight;
the lotus rhizome: 3.5 to 6.5 parts by weight;
the golden cypress: 4-7 parts by weight;
preparing calamine: 3.5 to 6 parts by weight.
6. The bezoar musk oroulcer powder according to claim 1, which is characterized in that:
the bezoar is as follows: 0.9 to 1.1 parts by weight;
the musk is as follows: 0.9 to 1.1 parts by weight;
the toad venom comprises the following components: 0.05 to 0.06 weight part;
the pearl is as follows: 4.5-6 parts by weight;
the amber powder comprises the following components: 4.5-6 parts by weight;
the black honeycomb: 4-6 parts by weight;
the calcination sand: 4.5-6 parts by weight;
and (3) indigo naturalis: 4.2 to 5.6 parts by weight;
the lotus rhizome: 4.2-6 parts by weight;
the golden cypress: 5-6 parts by weight;
preparing calamine: 4 to 5 parts by weight.
7. The bezoar musk oroulcer powder according to claim 1, which is characterized in that:
the bezoar is as follows: 1 part by weight;
the musk is as follows: 1 part by weight;
the toad venom comprises the following components: 0.055 parts by weight;
the pearl is as follows: 5 parts by weight;
the amber powder comprises the following components: 5.2 parts by weight;
the black honeycomb: 5 parts by weight;
the calcination sand: 5.4 parts by weight;
and (3) indigo naturalis: 5 parts by weight;
the lotus rhizome: 5 parts by weight;
the golden cypress: 5.5 parts by weight;
preparing calamine: 4.5 parts by weight.
8. The bezoar and musk aphthous ulcer powder as claimed in claim 1, wherein the raw materials further comprise the following components:
making homo, Cinnabaris, Catechu and SANMEI tablet.
9. The bezoar musk oroulcer powder of claim 8, which is characterized in that:
the human body whitening: 1-10 parts by weight;
the cinnabar: 1-10 parts by weight;
the catechu: 1-8 parts by weight;
the three-plum-leaf tablets comprise: 1 to 9 parts by weight.
10. The preparation method of the bezoar and musk aphtha powder is characterized by comprising the following steps:
weighing: weighing raw materials according to the formula of any one of claims 1 to 9;
a crushing step: crushing the pearls, the amber powder, the black honeycomb, the calcined sand, the indigo naturalis, the lotus, the golden cypress and the calamine in the raw materials to form crushed materials;
the synthesis steps are as follows: and putting the crushed materials into a container, uniformly stirring to form a mixture, putting the bezoar, the musk and the toad venom in the raw materials into the mixture, crushing, and sieving by using a sieve with more than 120 meshes to form the powder.
CN201910731229.5A 2019-08-08 2019-08-08 Bezoar musk aphtha powder and preparation method thereof Pending CN112336786A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910731229.5A CN112336786A (en) 2019-08-08 2019-08-08 Bezoar musk aphtha powder and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910731229.5A CN112336786A (en) 2019-08-08 2019-08-08 Bezoar musk aphtha powder and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112336786A true CN112336786A (en) 2021-02-09

Family

ID=74366862

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910731229.5A Pending CN112336786A (en) 2019-08-08 2019-08-08 Bezoar musk aphtha powder and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112336786A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1129132A (en) * 1995-12-14 1996-08-21 王利亚 Ulceromembrane of Chinese medicine and production technology thereof
CN1689621A (en) * 2004-04-21 2005-11-02 徐长山 Spraying agent for ulcer of oral cavity
CN105381003A (en) * 2015-11-19 2016-03-09 哈尔滨圣吉药业股份有限公司 Pearl and natural indigo buccal tablets and preparation method thereof
CN109498725A (en) * 2017-09-14 2019-03-22 刘从双 A kind of Chinese medicinal preparation method for treating aphtha

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1129132A (en) * 1995-12-14 1996-08-21 王利亚 Ulceromembrane of Chinese medicine and production technology thereof
CN1689621A (en) * 2004-04-21 2005-11-02 徐长山 Spraying agent for ulcer of oral cavity
CN105381003A (en) * 2015-11-19 2016-03-09 哈尔滨圣吉药业股份有限公司 Pearl and natural indigo buccal tablets and preparation method thereof
CN109498725A (en) * 2017-09-14 2019-03-22 刘从双 A kind of Chinese medicinal preparation method for treating aphtha

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
任一军,等: "双料喉风散临床新用", 《中国临床医生》 *
厦门市中医研究所,编: "《中医验方集》", 30 June 1959, 厦门人民出版社出版 *
吴国荣: "六神丸在口腔科的临床应用", 《陕西中医》 *
尹俊涛,等: "HPLC法同时测定口溃散中盐酸小檗碱和盐酸巴马汀的含量", 《现代中西医结合杂志》 *

Similar Documents

Publication Publication Date Title
EA029649B1 (en) Pomegranate-peel polyphenol gel used to treat gynecological inflammation diseases and method for preparation thereof
CN105250821B (en) A kind of compound Chinese medicinal preparation and preparation method thereof for treating ulcerative colitis
CN104524247B (en) One treats migrainous medical composition and its use
CN104147388B (en) Traditional Chinese medicine composition for treating migraine and preparation method thereof
CN114366776B (en) Traditional Chinese medicine preparation for treating infantile aphtha and preparation method thereof
CN112336786A (en) Bezoar musk aphtha powder and preparation method thereof
CN113663023A (en) A Ganoderma composition for treating hypertension and its preparation method
CN108785559B (en) Medicine for treating respiratory tract infection and preparation method thereof
CN113144141A (en) A Chinese medicinal composition for treating cough
CN102949712A (en) Chinese and western composite medicine for treating neoplastic diseases
CN102614461B (en) Spray for rapidly relieving stenocardia and preparation method thereof
CN102274428B (en) Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof
CN111035697A (en) Pharmaceutical composition and application thereof, preparation method of nanoparticles, extraction process of tea extract and tea extract
CN104623304A (en) Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion
CN105688171B (en) Feed additive for chicks and preparation method thereof
CN104587355A (en) Health-care product added with pomegranate
JP2004315455A (en) Agent for ameliorating or treating backache, pelvic pain or pain derived from varicosis in pregnancy or leg cramp
CN102614459B (en) Traditional Chinese medicine spray for rapidly curing myocardial ischemia and preparation method thereof
CN110151922B (en) Traditional Chinese medicine composition for treating angina pectoris complicated with hypertension and preparation method thereof
CN104840727B (en) Chinese medicine composition with anti-cancer of the esophagus activity and its preparation method and application
CN104491454A (en) Traditional Chinese medicine for treating dizziness due to hyperactivity of liver-yang and preparation method of traditional Chinese medicine
CN111228470A (en) A Chinese medicinal composition and its preparation method
CN102670957A (en) Health-care composition and preparation method and application thereof
CN115337368A (en) Medicine for treating various anorectal diseases and preparation method thereof
CN112402490A (en) Antibacterial, soothing and desquamation-preventing hand cream and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220307

Address after: 515322 No. 4, building 17, Xinxing District, Zhanlong Wei Zhanyang village, Zhanlong Town, Puning City, Jieyang City, Guangdong Province

Applicant after: Yang Changlv

Address before: 102100 room 1952, building 27, yard 8, Fenggu 4th Road, Yanqing garden, Zhongguancun, Yanqing District, Beijing

Applicant before: Beijing yangxianqing traditional Chinese Medicine Culture Institute

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210209